ALISON CHIMNER: Open Payments
NPI 1780090951 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,299 in 56 payments from 15 companies in 2025. Trend: 2023 $1,096 · 2024 $801 · 2025 $1,299
Food & beverage: $1,187Education: $111
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 12 | $247 |
| Otsuka America Pharmaceutical, Inc. | 9 | $187 |
| Teva Pharmaceuticals USA, Inc. | 4 | $171 |
| Corium, LLC | 6 | $158 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $86 |
| Janssen Pharmaceuticals, Inc | 3 | $86 |
| Supernus Pharmaceuticals, Inc. | 4 | $81 |
| Neurocrine BioSciences, Inc. | 3 | $58 |
| Tris Pharma Inc | 3 | $53 |
| Axsome Therapeutics, Inc. | 2 | $47 |
Products named: ARISTADA, Azstarys, REXULTI, CAPLYTA, Qelbree, INGREZZA, INVEGA SUSTENNA, Onyda XR.
Industry payments across MI — which companies pay providers there.
